O'Shaughnessy Asset Management, LLC Sarepta Therapeutics, Inc. Transaction History
O'Shaughnessy Asset Management, LLC
- $10.8 Billion
- Q3 2024
A detailed history of O'Shaughnessy Asset Management, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 3,839 shares of SRPT stock, worth $401,329. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,839
Previous 2,249
70.7%
Holding current value
$401,329
Previous $355,000
34.93%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding SRPT
# of Institutions
532Shares Held
84.5MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.08 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$937 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$654 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$456 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$446 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.15B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...